Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sanford Hillsberg currently holds 56,950 shares of Galena Biopharma, Inc. (GALE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sanford Hillsberg has been a net seller of GALE stock. They have purchased $0 and sold $4.9M worth of shares.
Sanford Hillsberg's most recent insider trade was on Oct 10, 2017, when they sold 20,997 shares at $0.38 per share.
Sanford Hillsberg serves as Executive at Galena Biopharma, Inc. (GALE). They have executed 65 insider transactions totaling $4.9M over their tenure at the company.
Sanford Hillsberg holds the position of Executive at Galena Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Sanford Hillsberg has shown a selling trading pattern, with $0 in total purchases and $4.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sanford Hillsberg was on Jan 17, 2014, when they sold $1.4M worth of GALE shares. This transaction involved 200,000 shares at $6.93 per share.
Sanford Hillsberg currently owns 56,950 shares of Galena Biopharma, Inc. (GALE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sanford Hillsberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sanford Hillsberg has 65 Form 4 filings on record as an insider at Galena Biopharma, Inc..
Set alerts for Sanford Hillsberg and 40,000+ other insiders.